Skip to content
Search

Latest Stories

Three pharmacists appointed as NIHR senior investigators

They will receive discretionary funding of £20,000 per year for four years to support their research activities.

Three pharmacists named in NIHR’s latest cohort of senior investigators

L-R: Professor David Alldred; Professor Rachel Elliott and Professor Ian Maidment.

The National Institute for Health and Care Research (NIHR) has announced its latest cohort of senior investigators, including three distinguished pharmacists.

David Alldred, professor of medicines use and safety at the University of Leeds; Rachel Elliott, professor of health economics at the University of Manchester; and Ian Maidment, professor in clinical pharmacy at Aston University, have been named in the list of 39 new appointments, alongside 19 reappointed senior investigators.


NIHR senior investigators are leading figures in research across social care, public health, pharmacy, dentistry, and clinical sciences.

They are recognised for “their exceptional contributions to research and their influence in shaping the future of health and care.”

Each senior investigator receives discretionary funding of £20,000 per year for four years to support their research activities while undertaking a senior leadership role within NIHR.

As NIHR Academy Members, they help “develop research capacity, guide strategy, and work closely with NIHR and the Department of Health and Social Care to address key challenges in health and social care.”

Professor Alldred emphasised how the award will help his team build on their work to enhance medicine safety for vulnerable and underserved populations, , such as older people living with frailty and people whose first language is not English.

“The award will also create further capacity for pharmacy-led research,” he told The Pharmaceutical Journal.

Professor Elliott highlighted her plans to "enhance public, patient, and community engagement in health economics through expanded training and funded projects, while promoting inclusion in the academic workforce by proactively reaching out to underrepresented professions, regions, and institutions.”

Professor Maidment underscored the key role of pharmacy in understanding how we can improve medication-related outcomes.

“I’m looking forward to continuing to support the vital work of the NIHR and develop the next generation of academic pharmacists and pharmacy technicians,” he told the publication.

Senior Investigators may apply for a second term upon completing their first, with a maximum tenure of two awards spanning up to eight years.

Applications for the next round of funding will open in June 2025.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less